Metabolic Syndrome (MetS) represents a group of clinical and biological criteria that when combined can become a potential threat for the development of severe pathologies -diabetes mellitus, cardiovascular disease, obesity. The International Diabetes Federation(IDF) defines the presence of MetS when 3 or more of the following criteria are detected: 1.raised triglycerides ?150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality
2.reduced HDL cholesterol <40 mg/dL (1.03 mmol/L) in males <50 mg/dL (1.29 mmol/L) in females or specific treatment for this lipid abnormality
3.raised blood pressure systolic BP ?130 or diastolic BP ?85 mm Hg or treatment of previously diagnosed hypertension
4.raised fasting plasma glucose, (FPG) ?100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes
5.central obesity (defined as waist circumference* with ethnicity specific values) (IDF guidelines)[1-3].